Your account's overdrawn dinotuhe The test will not be used on all women with breast cancer. Those considered at intermediate risk - and with oestrogen receptor positive (ER ), lymph node negative (LN-) and human epidermal growth factor receptor two negative (HER2-) subtypes of early breast cancer - will be tested to see if chemotherapy is necessary.